+9.35% for Injective — bullish momentum after major upgrade and Pineapple Financial interest

Traders Union
All News
Crypto News
Injective jumps 9.35% to $3.54 today

Highlights

Injective's IIP-619 mainnet upgrade passed on February 19, 2026, nearly unanimously, improving real-time EVM, MultiVM, and Chainlink integration.
Pineapple Financial accumulated over 7 million INJ tokens, about 7% of total supply, signaling strong institutional interest post-upgrade.
INJ trades at $3.54, just below daily Ichimoku Kijun resistance at $3.60, with technicals implying sideways consolidation between $3.20 and $3.85.

Institutional accumulation rises as mainnet upgrade enhances INJ network

On February 19, 2026, the Injective network approved the IIP-619 mainnet upgrade proposal with nearly unanimous validator support, enhancing its real-time EVM architecture and expanding MultiVM capabilities. The upgrade also bolsters Chainlink oracle integration for live price feeds and offers improvements for next-generation payment systems. Additionally, Pineapple Financial disclosed accumulating over 7 million INJ tokens, representing around 7% of the total supply, indicating institutional engagement following the network update.

Conflicting signals as intraday buying faces broader bearish momentum

Momentum indicators reveal a mixed picture for INJ. The MACD on the daily frame signals strong bearish momentum, while the ADX marks a prevailing trend with a selling bias. The RSI is neutral to slightly bearish, and Stochastic RSI indicates overbought conditions, suggesting caution as INJ may be overextended in the short term. Bull/Bear Power signals buyer dominance intraday, with price action showing strong upward momentum and high volatility as bulls test overhead resistance, though the rally is not yet fully confirmed by broader trend strength.

Range-bound outlook as persistent sell signals cap upside

For the next five trading days, the expected price range for INJ is $3.20 to $3.85, staying within a typical volatility band relative to current levels. The probability of a further price increase is low (less than 20%), as persistent sell signals remain on weekly Moving Averages, RSI, ADX, and MACD. The baseline view is for consolidation between immediate support and resistance, while a bullish outcome would require a sustained breakout above $3.60; failure at resistance may lead to a retest of support near $3.20.

Anton Kharitonov, analyst at Traders Union, sees short-term bullish momentum for INJ but notes that medium- and long-term signals remain weak. He highlights institutional interest following the network upgrade but is cautious due to strong sell signals on higher timeframes and mixed momentum indicators. The analyst expects consolidation between $3.20 and $3.85, with little evidence to support a sustained breakout. "Until INJ convincingly clears $3.60, I remain cautious and see limited upside in the near term."

Previously it was reported that Injective rallied above short-term moving averages but remains well below the long-term 200-day average, with price momentum diverging as intraday indicators turn overbought and medium-term signals stay weak. Immediate technical resistance stands at $3.61, with support near $3.25, as indicators such as MACD and ADX point to ongoing bearish momentum and a high probability of sideways to lower price movement in the near term.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.